ClinicalTrials.gov
ClinicalTrials.gov Menu

Single Embryo Transfer Versus Double Embryo Transfer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00814398
Recruitment Status : Terminated (Change in cryopreservation protocol)
First Posted : December 24, 2008
Last Update Posted : January 18, 2016
Sponsor:
Information provided by (Responsible Party):
Manuel Fernandez-Sanchez, IVI Sevilla

Brief Summary:
The aim of this project is to study the best number (1 or 2)and day (3 vs 5)of embryo transfer in good prognosis patient.

Condition or disease Intervention/treatment Phase
Infertility Procedure: Double Embryo Transfer (DET) Procedure: Single Embryo Transfer (SET) Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 199 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Single Embryo Transfer Versus Double Embryo Transfer in Day 3 or Blastocyst Stage
Study Start Date : December 2008
Actual Primary Completion Date : September 2009
Actual Study Completion Date : September 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Infertility
U.S. FDA Resources

Arm Intervention/treatment
Experimental: SET on day 3
Single embryo transfer on day 3 of embryo development
Procedure: Single Embryo Transfer (SET)
A single embryo is transferred during an IVF treatment
Experimental: DET on day 3
Double embryo transfer on day 3 of embryo development
Procedure: Double Embryo Transfer (DET)
Two embryos are transferred during an IVF treatment
Experimental: SET on day 5
Single embryo transfer on day 5 of embryo development
Procedure: Single Embryo Transfer (SET)
A single embryo is transferred during an IVF treatment
Experimental: DET on day 5
Double embryo transfer on day 5 of embryo development
Procedure: Double Embryo Transfer (DET)
Two embryos are transferred during an IVF treatment



Primary Outcome Measures :
  1. Live-birth delivery rate [ Time Frame: End of pregnancy (nine months after last transfer) ]

Secondary Outcome Measures :
  1. Multiple live-birth rate [ Time Frame: End of pregnancy (nine months after last transfer) ]
  2. Acceptance of assigned randomised group [ Time Frame: Day of randomisation ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 37 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:G

  • Good prognosis IVF patients

Exclusion Criteria:

  • Bad prognosis IVF patients

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00814398


Locations
Spain
IVI-Sevilla
Seville, Spain, 41011
Sponsors and Collaborators
IVI Sevilla
Investigators
Principal Investigator: Manuel Fernandez, MD IVI Sevilla

Responsible Party: Manuel Fernandez-Sanchez, Primary Investigator, IVI Sevilla
ClinicalTrials.gov Identifier: NCT00814398     History of Changes
Other Study ID Numbers: IVISEV-002SET
First Posted: December 24, 2008    Key Record Dates
Last Update Posted: January 18, 2016
Last Verified: March 2011

Keywords provided by Manuel Fernandez-Sanchez, IVI Sevilla:
Infertility
IVF
SET
DET
Blastocyst

Additional relevant MeSH terms:
Infertility
Genital Diseases, Male
Genital Diseases, Female